1. Home
  2. GROW vs PMN Comparison

GROW vs PMN Comparison

Compare GROW & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

HOLD

Current Price

$2.35

Market Cap

32.2M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$9.34

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROW
PMN
Founded
1968
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GROW
PMN
Price
$2.35
$9.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
45.0K
43.4K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$8,546,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$6.27
52 Week High
$2.78
$39.75

Technical Indicators

Market Signals
Indicator
GROW
PMN
Relative Strength Index (RSI) 41.97 89.39
Support Level $2.36 $7.35
Resistance Level $2.50 $9.26
Average True Range (ATR) 0.07 0.66
MACD 0.00 0.28
Stochastic Oscillator 0.00 99.12

Price Performance

Historical Comparison
GROW
PMN

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: